Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
6.71
-0.05 (-0.74%)
Apr 30, 2026, 2:35 PM CST
SHE:300289 Revenue
In the year 2025, Beijing Leadman Biochemistry had annual revenue of 326.31M CNY, down -11.86%. Beijing Leadman Biochemistry had revenue of 74.06M in the quarter ending December 31, 2025, a decrease of -16.23%.
Revenue
326.31M
Revenue Growth
-11.86%
P/S Ratio
11.57
Revenue / Employee
756.81K
Employees
420
Market Cap
3.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 326.31M | -43.92M | -11.86% |
| Dec 31, 2024 | 370.23M | -91.33M | -19.79% |
| Dec 31, 2023 | 461.55M | -244.42M | -34.62% |
| Jan 1, 2023 | 705.98M | 141.92M | 25.16% |
| Jan 1, 2022 | 564.06M | 92.55M | 19.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.09B |
| Zhejiang Orient Gene Biotech | 947.38M |
| Ningbo David Medical Device | 584.03M |
| Dirui Industrial | 511.11M |
| Chison Medical Technologies | 435.38M |
| Medprin Regenerative Medical Technologies | 373.49M |
| Kontour (Xi'an) Medical Technology | 351.08M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 339.54M |